Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about LAG3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
| Gene Symbol | LAG3 |
| Aliases | CD223 |
| Protein Type | Receptor |
| Function | LAG3 is primarily expressed on activated T cells, regulatory T cells (Tregs), natural killer cells, and to a lesser extent on B cells and dendritic cells. |
| Molecular Weight | 57 kDa |
| Pathways | Alpha-Synuclein Transmission |
| UniProt ID | [P18627](https://www.uniprot.org/uniprotkb/P18627) |
| GeneCards | LAG3 |
| Human Protein Atlas | LAG3 |
| Approach | Mechanism |
| Blocking antibodies | Prevent fibril binding/uptake |
| Soluble LAG3 | Decoy receptor for fibrils |
| Small molecule inhibitors | Block LAG3-fibril interaction |
| MHC Class II | Physiological |
| Alpha-synuclein fibrils | Pathological |
| Associated Diseases | Cancer, MICROGLIAL ACTIVATION, Parkinson's Disease |
| Interactions | APLP1, FOXP3, PI3K, RICTOR, MYC, RAGE |
| KG Connections | 121 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
LAG3(["LAG3"])
alpha_synuclein["alpha-synuclein"]
Co_inhibitory_Gene_Module["Co-inhibitory Gene Module"]
APLP1["APLP1"]
Alpha_Synuclein["Alpha-Synuclein"]
Alpha_Synuclein_Transmission["Alpha-Synuclein Transmission"]
Neurodegeneration["Neurodegeneration"]
Parkinson["Parkinson"]
PARKINSON["PARKINSON"]
Dopaminergic["Dopaminergic"]
Neuron["Neuron"]
FOXP3["FOXP3"]
RNA["RNA"]
PI3K["PI3K"]
RICTOR["RICTOR"]
AMYLOID["AMYLOID"]
LDHA["LDHA"]
MYC["MYC"]
neurodegeneration["neurodegeneration"]
LAG3 <-->|"interacts"| alpha_synuclein
LAG3 -->|"component_of"| Co_inhibitory_Gene_Module
APLP1 <-->|"interacts"| LAG3
LAG3 -->|"binds"| Alpha_Synuclein
LAG3 -->|"involved in"| Alpha_Synuclein_Transmission
LAG3 -->|"activates"| Neurodegeneration
LAG3 -->|"therapeutic_tar"| Parkinson
LAG3 -->|"therapeutic_tar"| PARKINSON
LAG3 <-->|"interacts"| APLP1
LAG3 -->|"activates"| Dopaminergic
LAG3 -->|"activates"| Neuron
LAG3 -.->|"inhibits"| FOXP3
LAG3 -.-|"associated"| RNA
LAG3 -.->|"inhibits"| PI3K
LAG3 -.->|"inhibits"| RICTOR
AMYLOID <-->|"interacts"| LAG3
LDHA -.->|"inhibits"| LAG3
MYC -.->|"inhibits"| LAG3
LAG3 -->|"implicated_in"| neurodegeneration
style LAG3 fill:#006494,stroke:#333,color:#e0e0e0,stroke-width:2px| Target | Relation | Type | Str |
|---|---|---|---|
| SNCA | binds | protein | 0.95 |
| alpha-synuclein | interacts_with | protein | 0.95 |
| microglial activation | mediates | process | 0.92 |
| Parkinson's Disease | therapeutic_target | disease | 0.91 |
| Alpha-Synuclein Transmission | involved_in | process | 0.90 |
| α-synuclein | facilitates_transmission_of | protein | 0.90 |
| Alpha-Synuclein Internalization | mediates | process | 0.90 |
| neuroinflammation | drives | process | 0.90 |
| A1 astrocyte | associated_with | cell_type | 0.90 |
| Alpha-Synuclein | binds | protein | 0.90 |
| alpha-synuclein | facilitates | protein | 0.90 |
| microglia | expressed_in | cell_type | 0.90 |
| Parkinson's Disease | implicated_in | disease | 0.90 |
| Parkinson'S Disease | therapeutic_target | disease | 0.90 |
| proinflammatory cytokines | upregulates | pathway | 0.89 |
| substantia nigra dopaminergic neurons | protects_against | cell_type | 0.86 |
| Dopaminergic Neurodegeneration | contributes_to | phenotype | 0.85 |
| α-synuclein pathology | suppresses | phenotype | 0.85 |
| co-inhibitory gene module | expressed_in | pathway | 0.85 |
| dopaminergic neuron | suppresses | cell_type | 0.85 |
| proinflammatory cytokine | associated_with | process | 0.85 |
| α-synucleinopathy | therapeutic_target | disease | 0.85 |
| microgliosis | suppresses | process | 0.84 |
| PI3K-Akt-Rictor pathway | inhibits | pathway | 0.80 |
| PI3K-Akt-Rictor | inhibits | pathway | 0.70 |
| MYC | interacts_with | gene | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Parkinson | therapeutic_target | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| NEURODEGENERATION | protects_against | phenotype | 0.65 |
| NEURODEGENERATION | inhibits | phenotype | 0.65 |
| NEURODEGENERATION | targets | phenotype | 0.65 |
| LACTATE | inhibits | phenotype | 0.65 |
| ASTROCYTES | activates | cell_type | 0.65 |
| ASTROCYTES | causes | cell_type | 0.65 |
| GLIOSIS | regulates | phenotype | 0.65 |
| MICROGLIAL ACTIVATION | causes | phenotype | 0.65 |
| MICROGLIA | regulates | cell_type | 0.65 |
| APLP1 | interacts_with | gene | 0.60 |
| FOXP3 | inhibits | gene | 0.60 |
| PI3K | inhibits | gene | 0.60 |
| RICTOR | inhibits | gene | 0.60 |
| MYC | inhibits | gene | 0.60 |
| TGFB1 | associated_with | gene | 0.60 |
| FOXP3 | associated_with | gene | 0.60 |
| CD163 | associated_with | gene | 0.60 |
| STAT5B | associated_with | gene | 0.60 |
| Il-6 | associated_with | protein | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| APLP1 | interacts_with | protein | 0.95 |
| microglia | expressed_in | cell_type | 0.94 |
| SNCA | interacts_with | protein | 0.93 |
| AKT | activates | gene | 0.65 |
| MYC | inhibits | gene | 0.60 |
| AKT | inhibits | gene | 0.60 |
| FOXP3 | inhibits | gene | 0.60 |
| TAU | inhibits | gene | 0.60 |
| MS4A4A | associated_with | gene | 0.60 |
| CCR8 | associated_with | gene | 0.60 |
| AMYLOID | interacts_with | gene | 0.60 |
| LDHA | inhibits | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| PARKINSON | activates | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| RICTOR | activates | gene | 0.50 |
| aplp1 | interacts_with | gene | 0.50 |
| aplp1 | activates | gene | 0.50 |
| Neurodegeneration | activates | disease | 0.50 |
| Pi3K | activates | pathway | 0.50 |
| SUBSTANTIA NIGRA | associated_with | brain_region | 0.50 |
| PARKINSON'S DISEASE | associated_with | disease | 0.45 |
| PARKINSON | associated_with | disease | 0.45 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||